Related Experiment Videos

From hypertension to heart failure -- are there better primary prevention strategies?

Peter A Meredith1, Jan Ostergren

  • 1Department of Medicine and Therapeutics, University of Glasgow, Glasgow, Scotland, UK. pam1v@clinmed.gla.ac.uk

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|November 4, 2006
PubMed

Insights

Heart failure is rising despite advances in cardiovascular disease care. Effective prevention in hypertensive patients requires tight blood pressure control, including agents that inhibit the renin-angiotensin-aldosterone system (RAAS).

Area of Science:

  • Cardiology
  • Hypertension Management
  • Heart Failure Prevention

Background:

  • Coronary heart disease (CHD) and stroke mortality are declining, but heart failure (HF) incidence and mortality are increasing globally.
  • Hypertension is a primary precursor to heart failure in most patients, necessitating improved blood pressure (BP) control.
  • Despite advances in hypertension management, many patients remain undiagnosed, untreated, or inadequately controlled.

Purpose of the Study:

  • To evaluate the role of hypertension management in heart failure prevention.
  • To assess the efficacy of newer antihypertensive strategies, particularly those targeting the renin-angiotensin-aldosterone system (RAAS).
  • To recommend optimal therapeutic approaches for primary prevention of heart failure in hypertensive individuals.

Main Methods:

  • Review of placebo-controlled trials in hypertension treatment, focusing on regimens including diuretics and beta-blockers.
  • Analysis of evidence for newer antihypertensive agents, including AT1-receptor blockers.
  • Examination of studies investigating the impact of RAAS inhibition on hypertension and heart failure outcomes.

Main Results:

  • Established antihypertensive therapies, including diuretics and beta-blockers, significantly reduce heart failure incidence.
  • AT1-receptor blockers demonstrate benefits beyond BP reduction, proving effective in treating both hypertension and heart failure.
  • Optimal prevention strategies necessitate multiple-drug regimens for tight and sustained BP control.

Conclusions:

  • Primary prevention of heart failure in hypertensive patients demands rigorous BP management.
  • Therapeutic strategies should incorporate agents that inhibit the renin-angiotensin-aldosterone system (RAAS) for enhanced efficacy.
  • Combined approaches targeting RAAS and achieving sustained BP control are crucial for reducing heart failure burden.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...